My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Viatris Inc. - Common Stock (NQ:VTRS)

16.13 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viatris Inc. - Common Stock

< Previous 1 2

...

14 15 16 17 18 19 20 21 Next >

Got $5,000? These 2 Dividend Stocks Are Dirt Cheap Buys ↗

September 02, 2021

And their yields are both over 3%.

Via The Motley Fool

3 Things About Pfizer That Smart Investors Know ↗

August 31, 2021

They're all about the future.

Via The Motley Fool

Theravance Stock Crashes; Can Longer Testing Salvage Its J&J-Partnered Drug? ↗

August 24, 2021

Theravance said late Monday its ulcerative colitis treatment failed in midstage testing, and the biotech stock plummeted early Tuesday.

Via Investor's Business Daily

3 Top Biotech Stocks to Buy in August ↗

August 17, 2021

Each of these companies makes for a great vehicle to play an aging demographic.

Via The Motley Fool

Analysts Love This Newly Formed Healthcare Company; Should You? ↗

August 16, 2021

Viatris' steady operating results and cheap valuation are two key reasons for its high one-year price target.

Via The Motley Fool

Unusual Options Activity Insight: Viatris ↗

August 09, 2021

On Monday, shares of Viatris (NASDAQ:VTRS) saw unusual opt...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Earnings Scheduled For May 10, 2021 ↗

May 10, 2021

Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report...

Via Benzinga

Viatris Inc (VTRS) Q2 2021 Earnings Call Transcript ↗

August 09, 2021

VTRS earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

How This Historic FDA Approval Benefits Viatris ↗

August 04, 2021

Here's what the FDA's approval of Semglee, from Viatris and Biocon, means for the former.

Via The Motley Fool

The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs ↗

July 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Earnings Scheduled For August 9, 2021 ↗

August 09, 2021

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •...

Via Benzinga

Viatris Stock Gains After FDA Approves Viatris-Biocon Biologics' Insulin Glargine Biosimilar Injection ↗

July 29, 2021

The FDA cleared Viatris inc (NASDAQ: VTRS) - Biocon Biologics' Semglee insulin glargine-yfgn injection as a biosimilar. Semglee indicates controlling high...

Via Benzinga

How To Find Value Stocks July 2021 ↗

July 21, 2021

Identifying fair value in an inflated stock market is really important, because in all markets, whether bull or bear you can always find value.

Via Talk Markets

10 Worst Performing S&P 500 Stocks Of 2021 ↗

July 02, 2021

The S&P 500 has continued its late-2020 momentum in the first two quarters of the year, gaining more than 15% year-to-date. Most U.S. investors have had a lot of winners in...

Via Benzinga

Topics Stocks

Why Viatris Stock Rocketed Higher in May ↗

June 08, 2021

This undervalued dividend stock finally found its footing in May.

Via The Motley Fool

2 Best Value Stocks to Buy Now ↗

May 31, 2021

Looking for solid companies trading on the cheap? Here are your top bets!

Via The Motley Fool

The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO ↗

June 24, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ...

Via Benzinga

2 Healthcare Stocks That Could Be Millionaire-Makers ↗

May 30, 2021

The combination of stability and innovation makes these giants safe bets for long-term returns.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021 ↗

June 15, 2021

Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an...

Via Benzinga

Is Viatris a Good Stock to Buy for 2021? ↗

May 30, 2021

Long-term investors might want to consider adding this recently formed pharmaceutical company to their portfolios.

Via The Motley Fool

Why Is No One Talking About Viatris Stock? ↗

May 27, 2021

This company is one of the largest manufacturers of generic pharmaceuticals in the world, but it may be underpriced.

Via The Motley Fool

Not Just GameStop, WallStreetBets' Target Melvin Capital Closed All Public Short Positions In Q1 ↗

May 19, 2021

Hedge fund Melvin Capital Management LP, which was at the heart of the GameStop Corp. (NYSE: GME) short squeeze frenzy earlier this year, closed out of all its public short...

Via Benzinga

Viatris Inc (VTRS) Q1 2021 Earnings Call Transcript ↗

May 10, 2021

VTRS earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Viatris Q1 Sales Tops Estimates, Reaffirms 2021 Outlook, Announces Quarterly Dividend ↗

May 10, 2021

Viatris Inc (NASDAQ: VTRS) reported Q1 net sales of $4.4 billion, down 6% Y/Y on a reported basis, but only down 2% compared to a combined loss of exclusivity...

Via Benzinga

Is Generic-Drug Maker Viatris a Keeper? ↗

May 09, 2021

It depends on what type of investor you are.

Via The Motley Fool

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

Cramer Shares His Thoughts On JetBlue, General Electric And More ↗

April 30, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said he is an EV guy, but you have got to pick which EV you want. He prefers Tesla, Inc. (NASDAQ: TSLA) over...

Via Benzinga

Wall Street Thinks This Dirt-Cheap Stock Will Soar 50% ↗

April 26, 2021

But that's not the best reason to consider buying it.

Via The Motley Fool

3 Best Value Stocks to Buy Now ↗

April 14, 2021

On the hunt for bargains in today's overvalued market? Look no further.

Via The Motley Fool

< Previous 1 2

...

14 15 16 17 18 19 20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.